{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:42:05Z","timestamp":1761972125702,"version":"build-2065373602"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,11,1]]},"DOI":"10.2169\/internalmedicine.5528-25","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T18:07:32Z","timestamp":1745863652000},"page":"3150-3154","source":"Crossref","is-referenced-by-count":0,"title":["Auto Immune Glial Fibrillary Acidic Protein Astrocytopathy Coexistent with Positivity for Anti-NH&lt;sub&gt;2&lt;\/sub&gt;-terminal of \u03b1-enolase Antibodies"],"prefix":"10.2169","volume":"64","author":[{"given":"Junichi","family":"Matsuo","sequence":"first","affiliation":[{"name":"Department of Neurology, Kumamoto Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Namitome","sequence":"additional","affiliation":[{"name":"Department of Neurology, Japanese Red Cross Kumamoto Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kumamoto Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Terasaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Japanese Red Cross Kumamoto Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuharu","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"doi-asserted-by":"crossref","unstructured":"1. Fang B, McKeon A, Hinson SR, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol 73: 1297-1307, 2016.","key":"1","DOI":"10.1001\/jamaneurol.2016.2549"},{"doi-asserted-by":"crossref","unstructured":"2. Flanagan EP, Hinson SR, Lennon VA, et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol 81: 298-309, 2017.","key":"2","DOI":"10.1002\/ana.24881"},{"doi-asserted-by":"crossref","unstructured":"3. Gravier-Dumonceau A, Ameli R, Rogemond V, et al. Glial fibrillary acidic protein autoimmunity: a French cohort study. Neurology 98: e653-e668, 2022.","key":"3","DOI":"10.1212\/WNL.0000000000013087"},{"doi-asserted-by":"crossref","unstructured":"4. Dubey D, Hinson SR, Jolliffe EA, et al. Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1 year. J Neuroimmunol 321: 157-163, 2018.","key":"4","DOI":"10.1016\/j.jneuroim.2018.04.016"},{"doi-asserted-by":"crossref","unstructured":"5. Kimura A. Clinical features and pathogenesis of glial fibrillary acidic protein (GFAP) antibody-associated disorders. Rinsho Shinkeigaku (Clin Neurol) 64: 75-84, 2024 (in Japanese).","key":"5","DOI":"10.5692\/clinicalneurol.cn-001925"},{"doi-asserted-by":"crossref","unstructured":"6. Ding J, Ren K, Wu J, et al. Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy. J Neurol 267: 2589-2593, 2020.","key":"6","DOI":"10.1007\/s00415-020-09869-2"},{"doi-asserted-by":"crossref","unstructured":"7. Martin AL, Jolliffe E, Hertweck SP. Ovarian teratoma associated with coexisting anti-N-methyl-D-aspartate receptor and glial fibrillary acidic protein autoimmune meningoencephalitis in an adolescent girl: a case report. J Pediatr Adolesc Gynecol 31: 321-324, 2018.","key":"7","DOI":"10.1016\/j.jpag.2017.12.009"},{"doi-asserted-by":"crossref","unstructured":"8. Zhang W, Xie Y, Wang Y, et al. Clinical characteristics and prognostic factors for short-term outcomes of autoimmune glial fibrillary acidic protein astrocytopathy: a retrospective analysis of 33 patients. Front Immunol 14: 1136955, 2023.","key":"8","DOI":"10.3389\/fimmu.2023.1136955"},{"doi-asserted-by":"crossref","unstructured":"9. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol 60: 164-171, 2003.","key":"9","DOI":"10.1001\/archneur.60.2.164"},{"doi-asserted-by":"crossref","unstructured":"10. Yoneda M, Matsunaga A, Ikawa M. Hashimoto&apos;s encephalopathy. In: Neuroimmunological Disease. Kusunoki S, Ed. Springer Japan, Tokyo, 2016: 235-244.","key":"10","DOI":"10.1007\/978-4-431-55594-0_15"},{"doi-asserted-by":"crossref","unstructured":"11. Natori T, Fukao T, Watanabe T, et al. Repeated brain magnetic resonance imaging provides clues for the diagnosis of autoimmune glial fibrillary acid protein astrocytopathy. Intern Med 61: 2947-2950, 2022.","key":"11","DOI":"10.2169\/internalmedicine.8964-21"},{"doi-asserted-by":"publisher","unstructured":"12. Imanaka S, Oka Y, Kimura A, Shimohata T, Matsumoto S. Autoimmune glial fibrillary acidic protein astrocytopathy with delayed abnormal magnetic resonance imaging findings. eNeurologicalSci 27: 100403, 2022.","key":"12","DOI":"10.1016\/j.ensci.2022.100403"},{"doi-asserted-by":"crossref","unstructured":"13. Mattozzi S, Sabater L, Escudero D, et al. Hashimoto encephalopathy in the 21st century. Neurology 94: e217-e224, 2020.","key":"13","DOI":"10.1212\/WNL.0000000000008785"},{"doi-asserted-by":"crossref","unstructured":"14. Fujii A, Yoneda M, Ito T, et al. Autoantibodies against the amino terminal of \u03b1-enolase are a useful diagnostic marker of Hashimoto&apos;s encephalopathy. J Neuroimmunol 162: 130-136, 2005.","key":"14","DOI":"10.1016\/j.jneuroim.2005.02.004"},{"doi-asserted-by":"crossref","unstructured":"15. Yoneda M, Fujii A, Ito A, Yokoyama H, Nakagawa H, Kuriyama M. High prevalence of serum autoantibodies against the amino terminal of \u03b1-enolase in Hashimoto&apos;s encephalopathy. J Neuroimmunol 185: 195-200, 2007.","key":"15","DOI":"10.1016\/j.jneuroim.2007.01.018"},{"doi-asserted-by":"crossref","unstructured":"16. Kishitani T, Matsunaga A, Ikawa M, et al. Limbic encephalitis associated with anti-NH<sub>2<\/sub>-terminal of \u03b1-enolase antibodies: a clinical subtype of Hashimoto encephalopathy. Medicine (Baltimore) 96: e6181, 2017.","key":"16","DOI":"10.1097\/MD.0000000000006181"},{"doi-asserted-by":"publisher","unstructured":"17. Hayashi Y, Yamada M, Kimura A, et al. Clinical findings of a probable case of MM2-cortical-type sporadic Creutzfeldt-Jakob disease with antibodies to anti-N-terminus of \u03b1-enolase. Prion 11: 454-464, 2017.","key":"17","DOI":"10.1080\/19336896.2017.1377876"},{"doi-asserted-by":"crossref","unstructured":"18. Sugiyama A, Suzuki M, Suichi T, et al. Gerstmann&apos;s syndrome in a patient double-positive for antibodies against the N-methyl-D-aspartate receptor and NH<sub>2<\/sub>-terminal of \u03b1-enolase. Intern Med 60: 1463-1468, 2021.","key":"18","DOI":"10.2169\/internalmedicine.6344-20"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/21\/64_5528-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:26:47Z","timestamp":1761967607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/21\/64_5528-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":18,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5528-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"article-number":"5528-25"}}